L Andersson. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Antifibrinolytic Agents/administration & dosageAntifibrinolytic Agents/adverse effectsAntifibrinolytic Agents/pharmacologyAntifibrinolytic Agents/therapeutic useDiarrhea/chemically inducedDisseminated Intravascular Coagulation/drug therapyFibrinolysisFibrinolytic Agents/physiologyFibrinolytic Agents/urineHematuria/drug therapyHemorrhage/drug therapyHemorrhage/etiologyHemorrhage/prevention & controlHeparin/therapeutic useHumansInjections, IntravenousKidney Diseases/drug therapyMaleNausea/chemically inducedPostoperative Complications/prevention & controlProstatectomyProstatic Neoplasms/complicationsUrinary Bladder Diseases/drug therapyUrologic Diseases/drug therapy
Substances： See more » Antifibrinolytic AgentsFibrinolytic AgentsHeparin
Year: 1972 PMID： 4670671 DOI： 10.1159/000392836
Source DB: PubMed Journal: Prog Surg ISSN： 0079-6824